(Q42944226)

11 November 2017

title

Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases (English)

1 reference

11 November 2017

1 reference

Karin Sorenmo

1

1 reference

11 November 2017

B. Overley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691027

18 June 2024

E. Krick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691027

18 June 2024

T. Ferrara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691027

18 June 2024

A. LaBlanc

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691027

18 June 2024

F. Shofer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20691027

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20691027

18 June 2024

publication date

1 September 2010

1 reference

full work available at URL

11 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1476-5829.2010.00222.x

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5829.2010.00222.x/fullpdf

18 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Veterinary and Comparative Oncology

18 June 2024

published in

1 reference

11 November 2017

volume

8

1 reference

11 November 2017

issue

3

1 reference

11 November 2017

page(s)

196-208

1 reference

The Therapy of Canine and Feline Lymphosarcoma

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma

18 June 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs

18 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma.

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Impact of chemotherapeutic dose intensity and hematologic toxicity on first remission duration in dogs with lymphoma treated with a chemoradiotherapy protocol

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Pounding in the neck in supraventricular tachycardia

18 June 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Targeting stem cells-clinical implications for cancer therapy

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.

18 June 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Targeting hedgehog in cancer stem cells: how a paradigm shift can improve treatment response

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Use of body surface area to calculate chemotherapeutic drug dose in dogs: II. Limitations imposed by pharmacokinetic factors

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1476-5829.2010.00222.X

18 June 2024

Identifiers

1 reference

11 November 2017

1 reference